Millipore Launches First Automated Cell Counter that Fits Into the Palm of the Hand

Thursday, November 19, 2009 General News J E 4

On Monday, December 7 at 7:30 a.m., in San Diego, Millipore will be hosting a press briefing to unveil a new and innovative instrument that will revolutionize cell counting for life science researchers. This transformational--and uniquely portable--technology provides a fast and accurate way of monitoring the health of cultures. John Sweeney, Vice President of Millipore's life science business, will present the instrument for the first time publicly, demonstrate it, and have it available for the media to see up-close.

Currently, manual cell counting is most commonly performed using a hemocytometer and a microscope. Because the process is manual and quite tedious, the accuracy and precision of cell counts can be impacted. Automated cell counters are also available but these bench top instruments are often expensive and are not portable.

Please join Millipore to hear more about this new, portable, high caliber cell counting technology over a light breakfast before attending the ASCB meeting on the 7th.

Date: Monday, December 7, 2009

Time: 7:30-8:00 a.m.

Location: Hard Rock Hotel San Diego, Corner of 5th Avenue & L Street, 207 5th Avenue (across from Convention Center)

Room: Revolution Room

RSVP: Lynn Blenkhorn: or 508-851-0930

Please Note: News on Millipore's New Cell Counter is Embargoed until December 7, 2009 at 7:30 a.m. PST

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees worldwide. For more information, visit


Greg Hoff



Lynn Blenkhorn

Feinstein Kean Healthcare


/PRNewswire -- Nov. 17/

SOURCE Millipore


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Practice Fusion Connects 1 Million Patients to The...
Sales of Therapies to Treat Diabetic Retinopathy, ...